Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dieter Dorsch is active.

Publication


Featured researches published by Dieter Dorsch.


Molecular Crystals and Liquid Crystals | 1991

Liquid Crystals with Polar Substituents Containing Fluorine: Synthesis and Physical Properties

Ekkehard Bartmann; Dieter Dorsch; Ulrich Finkenzeller

Abstract Liquid crystalline compounds with various polar terminal groups containing fluorine have been prepared (see below formula 1 with Z = S‒CHF2, S‒CF3, SO‒CHF2, SO‒CF3, SO2‒CHF2, SO2‒CF3, SO2F, OCH2CF3, CO‒OCH2CF3, CO‒CF3, CO‒CF2Cl, CO‒CF2H, CO‒CF2‒CH3, CO‒CF2‒C3H7). The synthesis of these compounds is outlined here and their physical properties (phase transitions, dielectric anisotropy, birefringence, viscosity) are discussed.


Bioorganic & Medicinal Chemistry Letters | 1994

(6-oxo-3-pyridazinyl)-benzimidazoles as potent angiotensin II receptor antagonists

Dieter Dorsch; Werner Mederski; Norbert Beier; Inge Lues; Klaus-Otto Dr. Minck; Pierre Schelling

The syntheses and angiotensin II antagonistic activities of novel (6-oxo-3-pyridazinyl)-benzimidazole derivatives are reported. Evaluation of the structure-activity relationships led to the discovery of potent orally active antihypertensive compounds.


Bioorganic & Medicinal Chemistry Letters | 1995

URACIL-BASED ANGIOTENSIN II RECEPTOR ANTAGONISTS

Dieter Dorsch; Werner Mederski; Mathias Osswald; Norbert Beier; Pierre Schelling

1,2,3,4-Tetrahydro-2,4-pyrimidinedione (uracil) is a valuable nucleus for the construction of potent antagonists of the AT1 angiotensin II receptor. Various synthetic routes were applied in order to introduce a wide range of different groups at the N3-nitrogen and to obtain condensed uracil derivatives as well. 121 with a N,N-dimethylacetamide residue at N3 was the most potent compound with an IC50 of 0.65 nM.


Archive | 2001

Substituted biphenyl derivatives

Horst Juraszyk; Dieter Dorsch; Werner Mederski; Christos Tsaklakidis; Christopher Bames; Johannes Gleitz


Archive | 1994

Imidazopyridazines being angiotensin II antagonists.

Dieter Dorsch; Werner Mederski; Mathias Osswald; Pierre Schelling; Norbert Beier; Ingeborg Lues; Klaus-Otto Dr. Minck


Journal of Medicinal Chemistry | 1994

Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.

Werner Mederski; Dieter Dorsch; Heinz-Hermann Bokel; Norbert Beier; Ingeborg Lues; Pierre Schelling


Archive | 1995

4-amino-1-piperidylbenzoylguanidines

Rolf Gericke; Manfred Baumgarth; Dieter Dorsch; Norbert Beier; Klaus-Otto Dr. Minck; Ingeborg Lues


Archive | 1998

Benzamidine derivatives as factor xa inhibitors

Dieter Dorsch; Horst Juraszyk; Hanns Wurziger; Sabine Bernotat-Danielowski; Guido Melzer


Archive | 1990

Electro-optical system containing a compensating film

Bernhard Scheuble; Bernhard Rieger; Dieter Dorsch


Archive | 2005

Squaric Acid Derivatives

Werner Mederski; Rolf Gericke; Dieter Dorsch; Markus Klein; Norbert Beier; Florian Lang

Researchain Logo
Decentralizing Knowledge